Trial intelligence / Profile preview

Postoperative nutritional status by pancrelipase dose after pancreatectomy

jRCTs051210012Recruiting

Start
Jun 2021
Modality
Replacement Enzymes → Therapeutic Enzymes → Recombinant Proteins and Enzymes
Countries
1
01

Overview

Randomised trial of Pancreaze in exocrine pancreatic insufficiency (EPI) (2 arms). Primary endpoint: Change of albumin level at 12 months after surgery. Started Jun 2021; status: recruiting.

02

Drugs

Pancreaze
03

Conditions

exocrine pancreatic insufficiency (EPI)

Beyond the preview

Go deeper on jRCTs051210012.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCTs051210012.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call